138 related articles for article (PubMed ID: 23315399)
1. Bioavailability of budesonide delivered by the clickhaler® and turbuhaler® dry powder inhalers in healthy volunteers : a pilot study.
Godfrey C; Buck H; Ellis S
Clin Drug Investig; 2002; 22(2):119-24. PubMed ID: 23315399
[TBL] [Abstract][Full Text] [Related]
2. Assessment of adrenal suppression from two new dry powder inhaler formulations of budesonide delivered by Clickhaler compared with the Pulmicort Turbuhaler.
Kirkpatrick C; Buck H; Ellis S
J Aerosol Med; 2003; 16(1):31-6. PubMed ID: 12737682
[TBL] [Abstract][Full Text] [Related]
3. Gamma scintigraphic evaluation of a novel budesonide dry powder inhaler using a validated radiolabeling technique.
Warren S; Taylor G; Smith J; Buck H; Parry-Billings M
J Aerosol Med; 2002; 15(1):15-25. PubMed ID: 12006142
[TBL] [Abstract][Full Text] [Related]
4. Equivalent lung deposition of budesonide in vivo: a comparison of dry powder inhalers using a pharmacokinetic method.
Lähelmä S; Kirjavainen M; Kela M; Herttuainen J; Vahteristo M; Silvasti M; Ranki-Pesonen M
Br J Clin Pharmacol; 2005 Feb; 59(2):167-73. PubMed ID: 15676038
[TBL] [Abstract][Full Text] [Related]
5. Dose-response comparison of budesonide dry powder inhalers using adenosine monophosphate bronchial challenge.
Lipworth BJ; Sims EJ; Das SK; Buck H; Paterson M
Ann Allergy Asthma Immunol; 2005 Jun; 94(6):675-81. PubMed ID: 15984601
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of budesonide Clickhaler and Turbuhaler in adult asthma.
Morice A; Das S; Ellis S;
J Asthma; 2005 Oct; 42(8):697-703. PubMed ID: 16266962
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma.
Virchow JC; Rodriguez-Roisin R; Papi A; Shah TP; Gopalan G
BMC Pulm Med; 2016 Mar; 16():42. PubMed ID: 26987997
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the systemic effects of budesonide inhaled from Easyhaler and from Turbuhaler in healthy male volunteers.
Hämäläinen KM; Granander M; Toivanen P; Malinen A
Respir Med; 2001 Nov; 95(11):863-9. PubMed ID: 11716199
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study.
Price DB; Thomas V; Richard Dekhuijzen PN; Bosnic-Anticevich S; Roche N; Lavorini F; Raju P; Freeman D; Nicholls C; Small IR; Sims E; Safioti G; Canvin J; Chrystyn H
BMC Pulm Med; 2018 Jun; 18(1):107. PubMed ID: 29954359
[TBL] [Abstract][Full Text] [Related]
10. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler.
Thorsson L; Edsbäcker S; Källén A; Löfdahl CG
Br J Clin Pharmacol; 2001 Nov; 52(5):529-38. PubMed ID: 11736861
[TBL] [Abstract][Full Text] [Related]
12. Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort
Gillen M; Forte P; Svensson JO; Lamarca R; Burke J; Rask K; Larsdotter Nilsson U; Eckerwall G
Pulm Pharmacol Ther; 2018 Oct; 52():7-17. PubMed ID: 30077809
[TBL] [Abstract][Full Text] [Related]
13. The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler.
Pedersen S; Steffensen G; Ohlsson SV
Br J Clin Pharmacol; 1993 Sep; 36(3):211-4. PubMed ID: 9114906
[TBL] [Abstract][Full Text] [Related]
14. Onset of action of budesonide/formoterol Spiromax(®) compared with budesonide/formoterol Turbuhaler(®) in patients with COPD.
Cazzola M; Ora J; Di Paolo A; Puxeddu E; Calzetta L; Rogliani P
Pulm Pharmacol Ther; 2016 Aug; 39():48-53. PubMed ID: 27344046
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler.
Toogood JH; White FA; Baskerville JC; Fraher LJ; Jennings B
J Allergy Clin Immunol; 1997 Feb; 99(2):186-93. PubMed ID: 9042043
[TBL] [Abstract][Full Text] [Related]
16. Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study.
Azouz W; Chetcuti P; Hosker H; Saralaya D; Chrystyn H
BMC Pulm Med; 2015 May; 15():47. PubMed ID: 25927483
[TBL] [Abstract][Full Text] [Related]
17. Airmax: a multi-dose dry powder inhaler.
Keating GM; Faulds D
Drugs; 2002; 62(13):1887-95; discussion 1896-7. PubMed ID: 12215059
[TBL] [Abstract][Full Text] [Related]
18. Budesonide + formoterol delivered via Spiromax
Lewis A; Torvinen S; Dekhuijzen PNR; Chrystyn H; Melani A; Zöllner Y; Kolbe K; Watson AT; Blackney M; Plich A
Respir Med; 2017 Aug; 129():179-188. PubMed ID: 28732829
[TBL] [Abstract][Full Text] [Related]
19. A study comparing the clinical pharmacokinetics, pharmacodynamics, and tolerability of triamcinolone acetonide HFA-134a metered-dose inhaler and budesonide dry-powder inhaler following inhalation administration.
Argenti D; Shah B; Heald D
J Clin Pharmacol; 2000 May; 40(5):516-26. PubMed ID: 10806605
[TBL] [Abstract][Full Text] [Related]
20. Budesonide/formoterol Turbuhaler®: a review of its use in chronic obstructive pulmonary disease.
Scott LJ
Drugs; 2012 Feb; 72(3):395-414. PubMed ID: 22316354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
